James B. Jones, SVP & Chief Medical Officer at Pacira Pharmaceuticals, Inc. (PCRX), bought 500 shares at $62.50 ($31K) on 2016-01-27, disclosed to the SEC on 2016-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCRX | BUY | 2016-01-14 | $66K | — | Filing → |